AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04863482 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IOC
Description: intra-operative cholangiography near-infrared fluorescence cholangiography
Study NCT05251350 — intervention group
Intervention type: PROCEDURE
Intervention: surgery
Description: our study is observational and we use secondary data
Study NCT05121610 — intervention group
Intervention type: PROCEDURE
Intervention: The procedures include PCI, CABG and HCR
Description: The procedures include PCI, CABG and HCR
Study NCT06435975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: Participants will perform a baseline +4000 steps/day for the duration of the study. Aerobic exercise, similar to a brisk walk, will be recommended as the primary mode of exercise.
Study NCT06435975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: Participants will complete a series of survey at multiple points throughout this study to assess quality of life issues. Questionnaires may be completed via paper forms with prepaid postage envelopes or using a REDCap online survey.
Study NCT06435975 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Lifestyle Coaching
Description: Participants will meet with a health coach, the Principal Investigator, to review baseline bowel habits and symptoms as well as discuss physical activity and potential strategies to achieve this goal, on a weekly basis for 12 weeks.
Study NCT06479369 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teaching training program
Description: The investigators will try to carry out a training based on motivational strategies for physical education teachers of the experimental group, with the aim of improving their motivational teaching style during physical education classes, and finally, to obtain benefits in their students, such as a greater adherence to physical activity.
Study NCT06345651 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Individually MR-neuronavigated TMS, 600 pulses, 120% RMT
Study NCT06345651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Individually MR-neuronavigated TMS, 600 pulses, 120% RMT
Study NCT05769556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain Gym Exercises
Description: Brain gym exercises is a collection of simple movements that function to stimulate the development of all parts of the brain synergistically.
Study NCT05769556 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physiotherapy
Description: A Group of exercises
Study NCT05945589 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Singapore A-Health Intervention
Description: The Singapore A-Health Intervention spanned 12 weeks, with each weekly session lasting for two hours. The program is structured around three thematic domains of the past, present, and future. In each thematic domain consisting of four weeks, participants were tasked with creating an artwork related to the theme and incorporating the learned art techniques. The structure of each thematic domain follows the same structure: the first week involved a 45-minute docent-led gallery tour on three selected pieces of artworks, followed by a 75-minute artist-led brainstorming session where participants were introduced to the techniques and discuss ideas on the artwork to be created. The subsequent three sessions involved further guidance from the artist and a scaffolded delivery of art techniques for participants to incorporate their learning to their artwork. At the end of each domain, there was a showcase where participants present their artwork.
Study NCT05151900 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Group for Caregivers
Description: Engage parents in the community via this support group, so they can be supported by other parents who know the system, can advise them on how to proceed, and empower them to help their children. Parents will learn psychoeducation about eating disorders and how to support their children.
Study NCT04810988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol
Description: The Unified Protocol is an empirically supported, transdiagnostic treatment for emotion disorders based on principles of cognitive behavioral therapy. Treatment focuses on increasing awareness of maladaptive thoughts and behaviors and decreasing avoidance of emotions and physiological sensations. Module 1 is focused on increasing motivation, readiness and self-efficacy for change. Module 2 focuses on increasing understanding and awareness of emotions. Module 3 is focused on further expanding awareness of emotions. Module 4 focuses on the role of thoughts in emotional disorders. Module 5 is focused on the role of behaviors in emotional disorders. Module 6 focuses on the role of physical sensations in emotional disorders. Module 7 focuses on exposure to interoceptive and situational triggers for emotions. Module 8 is focused on maintenance of treatment progress and relapse prevention.
Study NCT04810988 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unified Protocol
Description: The Unified Protocol is an empirically supported, transdiagnostic treatment for emotion disorders based on principles of cognitive behavioral therapy. Treatment focuses on increasing awareness of maladaptive thoughts and behaviors and decreasing avoidance of emotions and physiological sensations. Module 1 is focused on increasing motivation, readiness and self-efficacy for change. Module 2 focuses on increasing understanding and awareness of emotions. Module 3 is focused on further expanding awareness of emotions. Module 4 focuses on the role of thoughts in emotional disorders. Module 5 is focused on the role of behaviors in emotional disorders. Module 6 focuses on the role of physical sensations in emotional disorders. Module 7 focuses on exposure to interoceptive and situational triggers for emotions. Module 8 is focused on maintenance of treatment progress and relapse prevention.
Study NCT04810988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapist Support
Description: 4 video calls with study therapists
Study NCT05526131 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionare
Description: Assessing the presence or the absence of depression:~By structured clinical interview for DSM-IV Axis disorder (SCID-I) and Hamilton Depression Rating Scale (HAM-D) for diagnosing depression and exclusion of other psychiatric disorders.
Study NCT05833100 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CareSens PRO GK Blood Glucose/b-Ketone Monitoring system
Description: All BG results were compared to YSI 2300 reference method results obtained from subjects' capillary blood.~All Ketone results were compared to Randox Imola D-3-Hydroxybutyrate analyzer.
Study NCT05412251 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: health promotion program
Description: Multi-domain intervention 120 minutes cognitive training, 120 \~180 minutes physical exercise per weeks, and 60 minutes diet nutrition education per month
Study NCT04958200 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mhealth-pc for alcohol and pain
Description: Smartphone-based intervention that includes in-person initial session and 8 video lessons, daily activities, and weekly check-ins.
Study NCT04958200 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: psychoeducation on pain and alcohol use and treatment resource information
Study NCT04827472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal saline
Description: 100ml
Study NCT04827472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWJ1521
Description: Single dose
Study NCT04827472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012 Tablet
Description: Single dose, Tablet
Study NCT05834062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qsymia and lifestyle management therapy
Description: Qsymia will be used at 3.7g mg/23 mg for 12 weeks and then increased to 7.5 mg/46 mg for the remainder of the study. Participants will be offered lifestyle management therapy.
Study NCT05834062 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo and lifestyle management therapy
Description: Placebo will be used in lieu of Qsymia to maintain the blind. Participants will be offered lifestyle management therapy.
Study NCT05485922 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational device - intermittent catheter with a micro-hole zone
Description: The investigational device was a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.
Study NCT05485922 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Comparator device -VaPro intermittent catheter
Description: The comparator device is a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.
Study NCT05722262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: K-001
Description: K-877-ER and CSG452 combination tablet
Study NCT05479032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amantadine
Description: 2x100 mg Amantadine for 3-5 days (dosage can be doubled in case of missing response to treatment after 48 hours)
Study NCT05197283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose as reference food
Description: Fourteen healthy, normal weight subjects after 10-14 hours fast, consumed 50g glucose diluted in 300ml water, tested two times, in different visits, within 5-10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT05197283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White bread
Description: Fourteen healthy, normal weight subjects after 10-14 hours fast, consumed 50g available carbohydrates from white bread, along with 300ml water, tested two times, in different visits, within 10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT05197283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regular spaghetti
Description: Fourteen healthy, normal weight subjects after 10-14 hours fast, consumed 50g available carbohydrates from regular spaghetti No 7, along with 300ml water, tested once, within 10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT05197283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole wheat spaghetti
Description: Fourteen healthy, normal weight subjects after 10-14 hours fast, consumed 50g available carbohydrates from whole wheat spaghetti No 7, along with 300ml water, tested once, within 10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT05197283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High fibre - low carbohydrates spaghetti
Description: Fourteen healthy, normal weight subjects after 10-14 hours fast, consumed 50g available carbohydrates from high fibre - low carbohydrate spaghetti No 7, along with 300ml water, tested once, within 10 min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT05543707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PBI-0451 (Pomotrelvir)
Description: 2 × 350 mg tablets administered orally twice daily (BID) (1400 mg/day) with food for 5 days (10 total doses)
Study NCT05543707 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 × placebo to match PBI-0451(Pomotrelvir) tablets administered orally BID with food for 5 days (10 total doses)
Study NCT05336630 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Forceps
Description: The forceps clears the redundant tissue to enable access to the papilla, as well as stabilizes the ampullary position to permit an easier cannulation. The forceps is an FDA approved instrument and does not put the patient at any higher risk for any adverse event. Please note that for the explicit purpose of the study the forceps will be used to grab tissue and not take biopsies. The forceps may still be used to take biopsies if the physician believes it is indicated.
Study NCT05020535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MW189
Description: MW189 (0.25 mg/kg) is administered within 24 hours of symptom onset and every 12 hours for up to 5 days (10 total doses) or until discharge (if earlier than 5 days)
Study NCT05020535 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Administration of saline within 24 hours of symptom onset and every 12 hours for up to 5 days (10 total doses) or until discharge (if earlier than 5 days)
Study NCT06145438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dienogest
Description: Drug is administered orally at the same time every day
Study NCT06145438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Depo Medroxyprogesterone acetate
Description: Drug is injected intramuscularly on the buttock
Study NCT06145438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Leuprolide (as Leuprolide Acetate)
Description: Drug is injected intramuscularly on the buttock
Study NCT06145438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levonogestrel + etinilestradiol (30 mcg, brand name Mycrogynon)
Description: Drug is administered orally at the same time every day
Study NCT05540613 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Health Education
Description: A 26 weeks brain health and general health education program with two 1.5-hour sessions weekly.
Study NCT05722262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: K-877-ER
Description: K-877-ER tablet
Study NCT05722262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSG452
Description: CSG452 tablet
Study NCT05540613 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Exercise
Description: A 26 weeks Conventional Exercise training with two 1.5-hour sessions weekly.
Study NCT05540613 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: A 26 weeks Tai Chi training with two 1.5-hour sessions weekly.
Study NCT06515821 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ONCOSCREEN
Description: Subjects samples will be tested with diagnostic tests.
Study NCT06104813 — intervention group
Intervention type: OTHER
Intervention: Interviews
Description: Interview with volunteer, to ask them a series of open questions about sexual health in the deaf male population.
Study NCT06293274 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Discharge training
Description: What is motherhood blues? Why does it occur? What are its symptoms? How to deal with it? What is postpartum depression? What causes postpartum depression? Information is provided on this topic.
Study NCT05751798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OSE-279 100mg
Description: Human IgG4 mAb against PD-1
Study NCT05751798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OSE-279 300mg
Description: Human IgG4 mAb against PD-1
Study NCT05751798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OSE-279 500mg
Description: Human IgG4 mAb against PD-1
Study NCT05468255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: removal of exercise
Description: Subjects will stop doing their normal exercise routines for 3 or 5 days and then subjects will resume doing their normal exercise routines for 3 days.
Study NCT05750498 — intervention group
Intervention type: OTHER
Intervention: No interventions
Description: There are no interventions
Study NCT05061420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pharmaceutical Form: Concentration for solution for infusion Route of Administration: Intravenous Infusion
Study NCT05061420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR444245 (Thor-707)
Description: Pharmaceutical Form: Concentrate for solution for infusion Route of Administration: Intravenous Infusion
Study NCT05061420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Pharmaceutical Form: Solution for infusion Route of Administration: Intravenous Infusion
Study NCT06649331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: A HER2-directed ADC, via intravenous (into the vein) infusion per protocol.
Study NCT06649331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1921
Description: A TROP2-directed ADC, via intravenous (into the vein) infusion per protocol.
Study NCT06649331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A2009
Description: A HER3-directed ADC, via intravenous (into the vein) infusion per protocol.
Study NCT06649331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A2102
Description: A Nectin4-directed ADC, via intravenous (into the vein) infusion per protocol.
Study NCT04854824 — intervention group
Intervention type: DRUG
Intervention: Recommended treatment schedule
Description: Relatively selective Cox-2 inhibitors, Corticosteroids (Dexamethasone), Anticoagulants (LMW heparin), Gentle oxygen therapy
Study NCT04854824 — intervention group
Intervention type: DRUG
Intervention: Control treatment schedule
Description: Treatment regimens different from the recommended one according to family physician personal practice
Study NCT05599555 — intervention group
Intervention type: BIOLOGICAL
Intervention: mRNA BNT162b2 vaccine
Description: mRNA vaccine Comirnaty (BNT162b2 mRNA, BioNTech/Fosun-Pharma, Mainz, Germany/Shanghai, China)
Study NCT05599555 — intervention group
Intervention type: BIOLOGICAL
Intervention: CoronaVac vaccine
Description: Inactivated CoronaVac vaccine (Sinovac Life Sciences, Beijing, China)
Study NCT05427084 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Canagliflozin
Description: Canagliflozin tablet 300mg PO daily
Study NCT05427084 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet
Study NCT04446728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Training Webinar
Description: The training webinar is a three hour training. The purpose of the study is to implement the Psychosocial Assessment Tool (PAT) in their center.
Study NCT04446728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Training Webinar Plus Implementation Enhanced Resources (TIER)
Description: In addition the Training Webinar, sites randomized to Strategy II will identify a Champion and will participate in monthly consultation calls in support of implementation of the PAT
Study NCT06675825 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BougieCap
Description: The BougieCap is attached to the tip of the endoscope, offers direct visual and tactile control and the endoscope acts as a carrier of the radial and longitudinal force vectors for the dilation.
Study NCT06675825 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Savary-Bougie (A) or balloon dilation (B)
Description: A: In the Savary- Bougie treatment, dilators of different sizes are advanced to dilate the stenosis. The same procedure is then repeated with the next larger dilator, with the position of the dilator being checked radiologically each time.~B: In the case of balloon dilation, a balloon is inserted and inflated at the level of the stenosis. Depending on the age of the child and possibly also the etiology of the stenosis, different balloons sizes are applied, which are then maintained inflated for about one until three minutes and the respective pressure. This procedure could take place under endoscopic or radiological control.
Study NCT05038800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MK-0482
Description: IV infusion
Study NCT06723171 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IRX4204
Description: Active Treatment
Study NCT04891666 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum DSM 33464
Description: 1 sachet SmartGuard® per day for 12 weeks
Study NCT04891666 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 sachet of placebo per day for 12 weeks
Study NCT06492447 — intervention group
Intervention type: DRUG
Intervention: Against HER 2-ADC Drug
Description: Breast cancer subjects receiving anti-HER2-ADC drugs were treated with a 3-week treatment cycle lasting 6 cycles. Serum of patients before and after treatment was collected, and the changes of serum HER2 level before chemotherapy and after 2, 4 and 6 cycles of chemotherapy were dynamically monitored, and the relationship between HER2 level and the therapeutic effect of different targeted drugs was analyzed.
Study NCT05083663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Description: using hyaluronidase as an additive to bupivacaine
Study NCT05271565 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oligomeric enteral feeding
Description: Oligomeric enteral formula
Study NCT05271565 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Polymeric enteral feeding
Description: Polymeric enteral feeding will be administered to the PICU patients
Study NCT05084976 — intervention group
Intervention type: BEHAVIORAL
Intervention: COVID 19 vaccine counseling
Description: After surveys are completed, pulmonary provider (nurse practitioner or physician) will provide counseling via phone or in person about the COVID 19 vaccine. Safety, efficacy and side effects will be reviewed.
Study NCT05529537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual lymphatic drainage
Description: In addition to conventional treatment for 4 weeks, manual lymph drainage will be applied to the patients.